Cargando…
Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial
BACKGROUND: The diabetogenic action of statins remains a concern, particularly in patients at high risk for diabetes receiving intensive statin therapy. Despite the risk of diabetes with statin use being considered a potential class effect, recent studies have suggested that pitavastatin exerts neut...
Autores principales: | Park, Jun-Bean, Jung, Ji-Hyun, Yoon, Yeonyee E., Kim, Hack-Lyong, Lee, Seung-Pyo, Kim, Hyung-Kwan, Kim, Yong-Jin, Cho, Goo-Yeong, Sohn, Dae-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659042/ https://www.ncbi.nlm.nih.gov/pubmed/29078817 http://dx.doi.org/10.1186/s13063-017-2229-4 |
Ejemplares similares
-
Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020) -
Assessing Impact of High-Dose Pitavastatin on Carotid Artery Elasticity with Speckle-Tracking Strain Imaging
por: Kim, Chee Hae, et al.
Publicado: (2018) -
Statin diabetogenicity: guidance for clinicians
por: Ray, Kausik
Publicado: (2013) -
Diabetogenic Effect of Statins: A Double-Edged Sword?
por: Yoon, Ji Sung, et al.
Publicado: (2013) -
Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)